Homepage

Unlock their full potential

15 years of biosimilars

Our Purpose and Ambition

We are a global leader in generic and biosimilar pharmaceuticals, committed to driving access to medicine

Sandoz officially certified as Global Top Employer 2021

COVID-19 Information Center

The information center provides a central hub for news, guidance and resources.

Explore Novartis

About Us

Who We Are

Our Work

What We Do

About Us

Corporate Responsibility

Careers

Job Search

Recent Updates

Featured / Jul 21

Novartis Financial Results – Q2 2021

Novartis announced the company’s financial results for the second quarter and first half of 2021.

Media Release / Oct 11

Sandoz completes acquisition of GSK’s cephalosporin business, reinforcing leading global position in antibiotics

Media Release / Oct 01

Sandoz Resolves Legacy Federal Government Civil Investigation in the U.S. Regarding Generic Drugs

How can we build a better tomorrow for cancer patients?

Media Release / Sep 08

Sandoz strengthens pipeline by entering into agreement for biosimilar bevacizumab, a key oncology medicine

View All

On the occasion of National #ParalegalDay we would like to acknowledge and thank all our paralegals for truly livin… https://t.co/TLZHmO0h3E 1 day 6 hours ago

Our Work

At Sandoz, we discover new ways to improve and extend people’s lives. We pioneer novel approaches to help people around the world access high-quality medicine.

Learn More